Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The results of a new study on potential effects of empagliflozin for type 1 diabetes indicate empagliflozin may play a role in preserving beta cell regeneration and improving blood glucose control in type 1 diabetes patients.
Type 1 diabetes mellitus is a disease state that represents 5-10% of patients with diabetes in the United States. Type 1 diabetics are required to be on insulin, whereas, in type 2 diabetics insulin therapy is reserved for more severe cases. Type 1 diabetes is an autoimmune disorder that attacks the pancreatic beta cells, leading to severe insulin deficiency. Unfortunately, there is no known cure currently for type 1 diabetics. Due to their reliance on insulin, type 1 diabetics are at much greater risk of hypoglycemia. This creates great interest in the development of a non-insulin therapy for the management of type 1 diabetes.
http://www.diabetesincontrol.com/em...s-potentially-protects-pancreatic-beta-cells/
Type 1 diabetes mellitus is a disease state that represents 5-10% of patients with diabetes in the United States. Type 1 diabetics are required to be on insulin, whereas, in type 2 diabetics insulin therapy is reserved for more severe cases. Type 1 diabetes is an autoimmune disorder that attacks the pancreatic beta cells, leading to severe insulin deficiency. Unfortunately, there is no known cure currently for type 1 diabetics. Due to their reliance on insulin, type 1 diabetics are at much greater risk of hypoglycemia. This creates great interest in the development of a non-insulin therapy for the management of type 1 diabetes.
http://www.diabetesincontrol.com/em...s-potentially-protects-pancreatic-beta-cells/